Bromine in PDB 6tls: Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole
Enzymatic activity of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole
All present enzymatic activity of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole:
2.7.11.1;
Protein crystallography data
The structure of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole, PDB code: 6tls
was solved by
H.Czapinska,
A.Piasecka,
M.Winiewska-Szajewska,
M.Bochtler,
J.Poznanski,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
44.21 /
1.46
|
Space group
|
P 42 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
128.017,
128.017,
61.148,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
15.4 /
17.3
|
Other elements in 6tls:
The structure of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole also contains other interesting chemical elements:
Bromine Binding Sites:
The binding sites of Bromine atom in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole
(pdb code 6tls). This binding sites where shown within
5.0 Angstroms radius around Bromine atom.
In total 6 binding sites of Bromine where determined in the
Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole, PDB code: 6tls:
Jump to Bromine binding site number:
1;
2;
3;
4;
5;
6;
Bromine binding site 1 out
of 6 in 6tls
Go back to
Bromine Binding Sites List in 6tls
Bromine binding site 1 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 1 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br401
b:43.4
occ:0.70
|
BR1
|
A:NL2401
|
0.0
|
43.4
|
0.7
|
N8
|
A:NL2401
|
0.7
|
33.9
|
0.3
|
N9
|
A:NL2401
|
1.5
|
33.8
|
0.3
|
C7
|
A:NL2401
|
1.7
|
32.1
|
0.3
|
C4
|
A:NL2401
|
1.9
|
35.3
|
0.7
|
N5
|
A:NL2401
|
2.4
|
33.3
|
0.3
|
C6
|
A:NL2401
|
2.5
|
33.1
|
0.3
|
C3
|
A:NL2401
|
2.8
|
30.2
|
0.3
|
C1
|
A:NL2401
|
2.8
|
36.6
|
0.7
|
C6
|
A:NL2401
|
2.9
|
33.9
|
0.7
|
NE
|
A:ARG47
|
3.2
|
35.7
|
0.4
|
O
|
A:HOH871
|
3.2
|
46.6
|
0.7
|
O
|
A:HOH881
|
3.4
|
59.2
|
0.6
|
N5
|
A:NL2401
|
3.4
|
31.1
|
0.7
|
CD
|
A:ARG47
|
3.5
|
36.8
|
0.4
|
CZ
|
A:ARG47
|
3.6
|
35.1
|
0.4
|
CD1
|
A:ILE174
|
3.6
|
25.4
|
1.0
|
O
|
A:HOH564
|
3.7
|
41.5
|
0.7
|
O
|
A:HOH781
|
3.8
|
51.6
|
0.6
|
C4
|
A:NL2401
|
3.8
|
32.9
|
0.3
|
CG1
|
A:VAL53
|
3.9
|
33.5
|
1.0
|
NH2
|
A:ARG47
|
4.0
|
34.2
|
0.4
|
CG
|
A:ARG47
|
4.0
|
37.6
|
0.4
|
C2
|
A:NL2401
|
4.0
|
28.7
|
0.3
|
O
|
A:HOH873
|
4.0
|
51.9
|
0.6
|
CE
|
A:MET163
|
4.1
|
39.5
|
1.0
|
CG2
|
A:VAL53
|
4.1
|
35.3
|
1.0
|
C2
|
A:NL2401
|
4.1
|
37.3
|
0.7
|
C7
|
A:NL2401
|
4.2
|
33.1
|
0.7
|
NH1
|
A:ARG47
|
4.2
|
35.4
|
0.4
|
O
|
A:HOH916
|
4.2
|
54.9
|
0.6
|
O
|
A:HOH502
|
4.3
|
50.9
|
1.0
|
CB
|
A:VAL53
|
4.4
|
34.5
|
1.0
|
C1
|
A:NL2401
|
4.4
|
30.7
|
0.3
|
N9
|
A:NL2401
|
4.7
|
29.4
|
0.7
|
C3
|
A:NL2401
|
4.7
|
36.0
|
0.7
|
|
Bromine binding site 2 out
of 6 in 6tls
Go back to
Bromine Binding Sites List in 6tls
Bromine binding site 2 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 2 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br401
b:41.5
occ:0.30
|
BR1
|
A:NL2401
|
0.0
|
41.5
|
0.3
|
N8
|
A:NL2401
|
0.4
|
31.7
|
0.7
|
N9
|
A:NL2401
|
1.4
|
29.4
|
0.7
|
C7
|
A:NL2401
|
1.6
|
33.1
|
0.7
|
C4
|
A:NL2401
|
1.9
|
32.9
|
0.3
|
N5
|
A:NL2401
|
2.3
|
31.1
|
0.7
|
C6
|
A:NL2401
|
2.4
|
33.9
|
0.7
|
O
|
A:HOH754
|
2.7
|
23.2
|
0.7
|
C3
|
A:NL2401
|
2.7
|
36.0
|
0.7
|
C1
|
A:NL2401
|
2.8
|
30.7
|
0.3
|
C6
|
A:NL2401
|
2.8
|
33.1
|
0.3
|
N
|
A:ASP175
|
3.0
|
21.9
|
1.0
|
O
|
A:HOH754
|
3.2
|
21.1
|
0.3
|
CA
|
A:ASP175
|
3.3
|
22.3
|
1.0
|
N5
|
A:NL2401
|
3.3
|
33.3
|
0.3
|
NZ
|
A:LYS68
|
3.5
|
31.2
|
1.0
|
C4
|
A:NL2401
|
3.7
|
35.3
|
0.7
|
CZ
|
A:PHE113
|
3.9
|
22.9
|
1.0
|
C2
|
A:NL2401
|
3.9
|
37.3
|
0.7
|
C2
|
A:NL2401
|
4.0
|
28.7
|
0.3
|
CB
|
A:ASP175
|
4.1
|
24.3
|
1.0
|
C7
|
A:NL2401
|
4.1
|
32.1
|
0.3
|
CD
|
A:LYS68
|
4.1
|
31.8
|
1.0
|
CE2
|
A:PHE113
|
4.1
|
23.4
|
1.0
|
CB
|
A:ILE174
|
4.1
|
23.0
|
1.0
|
C
|
A:ILE174
|
4.2
|
21.0
|
1.0
|
CE
|
A:LYS68
|
4.2
|
33.1
|
1.0
|
C1
|
A:NL2401
|
4.3
|
36.6
|
0.7
|
CA
|
A:ILE174
|
4.4
|
21.7
|
1.0
|
CE1
|
A:PHE113
|
4.5
|
22.6
|
1.0
|
N
|
A:TRP176
|
4.5
|
21.4
|
1.0
|
C
|
A:ASP175
|
4.5
|
21.5
|
1.0
|
OE2
|
A:GLU81
|
4.5
|
26.3
|
1.0
|
CG
|
A:ASP175
|
4.6
|
27.1
|
1.0
|
C3
|
A:NL2401
|
4.6
|
30.2
|
0.3
|
N9
|
A:NL2401
|
4.6
|
33.8
|
0.3
|
OD1
|
A:ASP175
|
4.6
|
27.2
|
1.0
|
O
|
A:HOH564
|
4.8
|
41.5
|
0.7
|
CD2
|
A:PHE113
|
4.8
|
23.2
|
1.0
|
CD1
|
A:ILE174
|
4.9
|
25.4
|
1.0
|
CG1
|
A:ILE174
|
4.9
|
23.5
|
1.0
|
N8
|
A:NL2401
|
5.0
|
33.9
|
0.3
|
|
Bromine binding site 3 out
of 6 in 6tls
Go back to
Bromine Binding Sites List in 6tls
Bromine binding site 3 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 3 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br401
b:59.1
occ:0.70
|
BR2
|
A:NL2401
|
0.0
|
59.1
|
0.7
|
BR2
|
A:NL2401
|
0.2
|
22.5
|
0.3
|
C2
|
A:NL2401
|
1.9
|
37.3
|
0.7
|
C2
|
A:NL2401
|
1.9
|
28.7
|
0.3
|
C1
|
A:NL2401
|
2.8
|
30.7
|
0.3
|
C1
|
A:NL2401
|
2.8
|
36.6
|
0.7
|
C3
|
A:NL2401
|
2.8
|
36.0
|
0.7
|
C3
|
A:NL2401
|
2.9
|
30.2
|
0.3
|
CD1
|
A:ILE95
|
3.3
|
26.9
|
1.0
|
CG1
|
A:ILE95
|
3.5
|
26.0
|
1.0
|
CG2
|
A:VAL116
|
3.6
|
43.9
|
1.0
|
CB
|
A:PHE113
|
3.7
|
22.9
|
1.0
|
O
|
A:GLU114
|
3.9
|
28.8
|
0.4
|
CB
|
A:VAL66
|
4.0
|
27.6
|
1.0
|
CG
|
A:PHE113
|
4.0
|
22.5
|
1.0
|
CG1
|
A:VAL66
|
4.1
|
28.2
|
1.0
|
C4
|
A:NL2401
|
4.1
|
32.9
|
0.3
|
CG2
|
A:VAL66
|
4.1
|
28.7
|
1.0
|
C7
|
A:NL2401
|
4.1
|
33.1
|
0.7
|
C4
|
A:NL2401
|
4.1
|
35.3
|
0.7
|
O
|
A:GLU114
|
4.2
|
30.7
|
0.6
|
C7
|
A:NL2401
|
4.2
|
32.1
|
0.3
|
CD2
|
A:PHE113
|
4.3
|
23.2
|
1.0
|
CG2
|
A:ILE174
|
4.5
|
24.4
|
1.0
|
C6
|
A:NL2401
|
4.7
|
33.9
|
0.7
|
C6
|
A:NL2401
|
4.7
|
33.1
|
0.3
|
CD1
|
A:PHE113
|
4.7
|
22.8
|
1.0
|
CB
|
A:VAL116
|
4.7
|
43.8
|
1.0
|
CG1
|
A:VAL116
|
4.7
|
45.6
|
1.0
|
CB
|
A:ILE95
|
4.9
|
24.3
|
1.0
|
O
|
A:HOH700
|
4.9
|
27.4
|
0.6
|
N
|
A:VAL116
|
4.9
|
38.8
|
1.0
|
|
Bromine binding site 4 out
of 6 in 6tls
Go back to
Bromine Binding Sites List in 6tls
Bromine binding site 4 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 4 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br401
b:22.5
occ:0.30
|
BR2
|
A:NL2401
|
0.0
|
22.5
|
0.3
|
BR2
|
A:NL2401
|
0.2
|
59.1
|
0.7
|
C2
|
A:NL2401
|
1.8
|
37.3
|
0.7
|
C2
|
A:NL2401
|
1.9
|
28.7
|
0.3
|
C1
|
A:NL2401
|
2.8
|
36.6
|
0.7
|
C1
|
A:NL2401
|
2.8
|
30.7
|
0.3
|
C3
|
A:NL2401
|
2.8
|
30.2
|
0.3
|
C3
|
A:NL2401
|
2.8
|
36.0
|
0.7
|
CD1
|
A:ILE95
|
3.5
|
26.9
|
1.0
|
CG2
|
A:VAL116
|
3.6
|
43.9
|
1.0
|
CG1
|
A:ILE95
|
3.7
|
26.0
|
1.0
|
CB
|
A:PHE113
|
3.7
|
22.9
|
1.0
|
CB
|
A:VAL66
|
3.8
|
27.6
|
1.0
|
CG1
|
A:VAL66
|
3.9
|
28.2
|
1.0
|
O
|
A:GLU114
|
3.9
|
28.8
|
0.4
|
CG2
|
A:VAL66
|
4.0
|
28.7
|
1.0
|
CG
|
A:PHE113
|
4.0
|
22.5
|
1.0
|
C4
|
A:NL2401
|
4.1
|
32.9
|
0.3
|
C4
|
A:NL2401
|
4.1
|
35.3
|
0.7
|
C7
|
A:NL2401
|
4.1
|
32.1
|
0.3
|
C7
|
A:NL2401
|
4.1
|
33.1
|
0.7
|
O
|
A:GLU114
|
4.2
|
30.7
|
0.6
|
CD2
|
A:PHE113
|
4.3
|
23.2
|
1.0
|
C6
|
A:NL2401
|
4.6
|
33.1
|
0.3
|
C6
|
A:NL2401
|
4.6
|
33.9
|
0.7
|
CG2
|
A:ILE174
|
4.7
|
24.4
|
1.0
|
CD1
|
A:PHE113
|
4.8
|
22.8
|
1.0
|
CB
|
A:VAL116
|
4.8
|
43.8
|
1.0
|
CG1
|
A:VAL116
|
4.8
|
45.6
|
1.0
|
N
|
A:VAL116
|
4.9
|
38.8
|
1.0
|
|
Bromine binding site 5 out
of 6 in 6tls
Go back to
Bromine Binding Sites List in 6tls
Bromine binding site 5 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 5 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br402
b:54.8
occ:0.40
|
BR1
|
A:NL2402
|
0.0
|
54.8
|
0.4
|
C4
|
A:NL2402
|
1.9
|
54.5
|
0.4
|
NE2
|
A:GLN36
|
2.1
|
39.7
|
0.6
|
O
|
A:HOH921
|
2.5
|
41.7
|
0.6
|
C1
|
A:NL2402
|
2.8
|
54.0
|
0.4
|
C6
|
A:NL2402
|
2.9
|
54.6
|
0.4
|
O
|
A:THR108
|
3.0
|
47.6
|
1.0
|
CD
|
A:GLN36
|
3.2
|
38.6
|
0.6
|
N5
|
A:NL2402
|
3.4
|
55.3
|
0.4
|
OE1
|
A:GLN36
|
3.4
|
47.8
|
0.4
|
OE1
|
A:GLN36
|
3.6
|
39.8
|
0.6
|
CB
|
A:ASP103
|
3.6
|
52.6
|
0.5
|
CB
|
A:ASP103
|
3.7
|
53.0
|
0.5
|
CG2
|
A:ILE69
|
3.8
|
37.6
|
0.6
|
CB
|
A:ALA110
|
3.8
|
32.0
|
1.0
|
N
|
A:ASP103
|
3.9
|
49.6
|
0.5
|
N
|
A:ASP103
|
3.9
|
49.5
|
0.5
|
C
|
A:THR108
|
3.9
|
49.3
|
1.0
|
CB
|
A:THR108
|
4.0
|
55.1
|
1.0
|
O
|
A:HOH912
|
4.0
|
44.7
|
0.6
|
CD1
|
A:ILE69
|
4.0
|
36.2
|
0.4
|
CG2
|
A:ILE69
|
4.1
|
37.1
|
0.4
|
C2
|
A:NL2402
|
4.2
|
54.2
|
0.4
|
C7
|
A:NL2402
|
4.2
|
54.5
|
0.4
|
CG1
|
A:ILE69
|
4.2
|
36.9
|
0.6
|
CA
|
A:ASP103
|
4.3
|
53.0
|
0.5
|
CA
|
A:ASP103
|
4.3
|
52.8
|
0.5
|
CG2
|
A:THR108
|
4.3
|
55.2
|
1.0
|
CD1
|
A:ILE69
|
4.3
|
37.8
|
0.6
|
CD
|
A:GLN36
|
4.4
|
46.8
|
0.4
|
O
|
A:PRO109
|
4.4
|
36.7
|
1.0
|
C
|
A:PRO109
|
4.4
|
36.8
|
1.0
|
CA
|
A:THR108
|
4.5
|
54.0
|
1.0
|
CG
|
A:GLN36
|
4.5
|
37.4
|
0.6
|
CB
|
A:ILE69
|
4.5
|
37.0
|
0.6
|
N
|
A:ALA110
|
4.6
|
32.5
|
1.0
|
OD2
|
A:ASP103
|
4.6
|
53.9
|
0.5
|
N9
|
A:NL2402
|
4.7
|
55.1
|
0.4
|
C3
|
A:NL2402
|
4.7
|
54.5
|
0.4
|
CG
|
A:ASP103
|
4.7
|
54.3
|
0.5
|
CG
|
A:ASP103
|
4.7
|
53.7
|
0.5
|
N
|
A:PRO109
|
4.8
|
45.5
|
1.0
|
CA
|
A:ALA110
|
4.8
|
31.4
|
1.0
|
NE2
|
A:GLN36
|
4.8
|
47.9
|
0.4
|
C
|
A:LYS102
|
4.8
|
47.5
|
1.0
|
CB
|
A:GLN36
|
4.8
|
36.7
|
0.6
|
N
|
A:THR108
|
5.0
|
56.9
|
1.0
|
OG
|
A:SER106
|
5.0
|
69.7
|
1.0
|
CA
|
A:PRO109
|
5.0
|
41.5
|
1.0
|
CG1
|
A:ILE69
|
5.0
|
36.2
|
0.4
|
CB
|
A:ILE69
|
5.0
|
36.4
|
0.4
|
|
Bromine binding site 6 out
of 6 in 6tls
Go back to
Bromine Binding Sites List in 6tls
Bromine binding site 6 out
of 6 in the Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole
Mono view
Stereo pair view
|
A full contact list of Bromine with other atoms in the Br binding
site number 6 of Human CK2 Kinase Alpha Subunit in Complex with the Atp-Competitive Inhibitor 4,6-Dibromobenzotriazole within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Br402
b:55.2
occ:0.40
|
BR2
|
A:NL2402
|
0.0
|
55.2
|
0.4
|
C2
|
A:NL2402
|
1.9
|
54.2
|
0.4
|
CG
|
A:GLN36
|
2.0
|
37.4
|
0.6
|
CD
|
A:GLN36
|
2.7
|
38.6
|
0.6
|
C1
|
A:NL2402
|
2.8
|
54.0
|
0.4
|
C3
|
A:NL2402
|
2.9
|
54.5
|
0.4
|
OE1
|
A:GLN36
|
3.1
|
39.8
|
0.6
|
CB
|
A:GLN36
|
3.3
|
36.7
|
0.6
|
CG
|
A:GLN36
|
3.4
|
45.6
|
0.4
|
O
|
A:GLN36
|
3.5
|
35.0
|
0.6
|
CB
|
A:TYR39
|
3.6
|
32.6
|
0.4
|
NE2
|
A:GLN36
|
3.7
|
39.7
|
0.6
|
O
|
A:HOH853
|
3.7
|
50.9
|
0.6
|
CB
|
A:TYR39
|
3.7
|
32.8
|
0.6
|
CA
|
A:GLN36
|
3.7
|
34.7
|
0.6
|
CG1
|
A:VAL67
|
3.7
|
28.5
|
1.0
|
CG2
|
A:VAL67
|
3.9
|
27.3
|
1.0
|
CG2
|
A:VAL101
|
3.9
|
35.5
|
1.0
|
CD2
|
A:TYR39
|
3.9
|
32.2
|
0.6
|
CD
|
A:GLN36
|
4.0
|
46.8
|
0.4
|
CG
|
A:TYR39
|
4.1
|
32.3
|
0.6
|
C
|
A:GLN36
|
4.1
|
34.9
|
0.6
|
C4
|
A:NL2402
|
4.1
|
54.5
|
0.4
|
C7
|
A:NL2402
|
4.2
|
54.5
|
0.4
|
CD2
|
A:TYR39
|
4.2
|
31.6
|
0.4
|
CG
|
A:TYR39
|
4.3
|
31.9
|
0.4
|
O
|
A:TYR39
|
4.4
|
34.6
|
0.4
|
CB
|
A:VAL67
|
4.4
|
27.0
|
1.0
|
O
|
A:GLN36
|
4.5
|
41.8
|
0.4
|
OE1
|
A:GLN36
|
4.5
|
47.8
|
0.4
|
CD2
|
A:LEU41
|
4.6
|
33.1
|
1.0
|
NE2
|
A:GLN36
|
4.6
|
47.9
|
0.4
|
C6
|
A:NL2402
|
4.7
|
54.6
|
0.4
|
CB
|
A:GLN36
|
4.7
|
43.9
|
0.4
|
CG2
|
A:VAL112
|
4.8
|
25.9
|
1.0
|
CA
|
A:TYR39
|
4.8
|
33.3
|
0.4
|
CA
|
A:TYR39
|
4.9
|
33.1
|
0.6
|
CA
|
A:GLN36
|
4.9
|
42.8
|
0.4
|
C
|
A:TYR39
|
4.9
|
33.9
|
0.4
|
CE2
|
A:TYR39
|
5.0
|
31.9
|
0.6
|
CB
|
A:ALA110
|
5.0
|
32.0
|
1.0
|
|
Reference:
H.Czapinska,
A.Piasecka,
M.Winiewska-Szajewska,
M.Bochtler,
J.Poznanski.
Binding of Bromobenzotriazoles By the Catalytic Subunit of Human Protein Kinase CK2: Structural and Thermodynamics Studies. To Be Published.
Page generated: Thu Jul 11 02:45:11 2024
|